Weekly News

Venture Category: Biotechnology


This week's biotechnology venture startup news



Adaptive Phage Therapeutics - Senior Software Engineer
Position Description:  Senior Software Engineer Exciting opportunity for a Senior Software Engineer to join the team at Adaptive Phage Therapeutics (APT). The Senior Software Engineer will oversee the computational approach to interpreting the data from HRQT assays. Responsibilities: Development and operation of bioinformatics pipeline – Using commercial and open source software the candidate shall implement and robust pipeline […]
    Area9 Lyceum - FORBES: The Importance Of Soft Skills In A Post-Pandemic World
    
    
      Benchling - The Top 6 Questions R&D Organizations Struggle to Answer with Legacy Data Management
      The life science industry is shifting to a new model to support the next generation of therapeutic development. R&D has become more specialized and more collaborative, and produces vast amounts of highly complex data. In order to stay competitive, life science companies need data systems that help address a new set of challenges. Teams are […]
      The post The Top 6 Questions R&D Organizations Struggle to Answer with Legacy Data Management appeared first on Benchling.
      
        BioSapien Inc - New Study Shows Coming out as a Bisexuals May Increase Risk of Smoking
        The post New Study Shows Coming out as a Bisexuals May Increase Risk of Smoking appeared first on Conduct Science.
        
          BioSapien Inc - The Conduct Science Podcast: Fire
          The post The Conduct Science Podcast: Fire appeared first on Conduct Science.
          
            Cue Biopharma - Director/Senior Director of Clinical Operations
            Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. Cue Biopharma is a high growth company and is listed on NASDAQ (CUE). The company is located in Cambridge, Massachusetts […]
            The post Director/Senior Director of Clinical Operations appeared first on Cue Biopharma.
            
              Cue Biopharma - SITC Annual Meeting
              The post SITC Annual Meeting appeared first on Cue Biopharma.
              
                Cue Biopharma - SITC Annual Meeting
                The post SITC Annual Meeting appeared first on Cue Biopharma.
                
                  Cue Biopharma - SITC Annual Meeting
                  The post SITC Annual Meeting appeared first on Cue Biopharma.
                  
                    Decibel Therapeutics - Decibel Therapeutics Announces $82M Series D Financing to Advance Gene Therapies to Restore Hearing and Balance
                    — Proceeds support advancement of lead gene therapy programs and accelerate development of therapeutics to restore functional hair cells in…
                    The post Decibel Therapeutics Announces $82M Series D Financing to Advance Gene Therapies to Restore Hearing and Balance appeared first on Decibel Therapeutics.
                    
                      DTx Pharma - DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
                      PR Newswire, San Diego – November 9, 2020 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today the appointment of Denise Bevers as Chief Operating Officer. In this role, Ms. Bevers will oversee a broad range of operational areas including corporate [...]
                      The post DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer appeared first on DTX Pharma.
                      
                        Embark - Protected: Happy Dogsgiving
                        There is no excerpt because this is a protected post.
                        The post Protected: Happy Dogsgiving appeared first on Embarkvet.
                        
                          EpiFinder - Autism Resources to Help Families and Adults
                          Finding quality resources can be a challenge for autistic people and their loved ones. Here's what we recommend.
                          The post Autism Resources to Help Families and Adults appeared first on EpiFinder.
                          
                            Gemini Therapeutics - Gemini Therapeutics Announces GEM103 Meets All Endpoints in Phase 1 Clinical Study
                            Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that the Phase 1 study of GEM103, the Company’s investigational treatment for dry AMD, met all its endpoints.
                            The post Gemini Therapeutics Announces GEM103 Meets All Endpoints in Phase 1 Clinical Study appeared first on Gemini Therapeutics.
                            
                              Genialis - Genialis Harnesses RNA-seq Platform to Advance Precision Medicine Discoveries
                              New partnerships in oncology R&D, software advances, and the appointment of a new Board member help drive therapeutic breakthroughs Read the press release in its entirety here.
                                Hesperos - Dr. Hickman Presents Human-on-a-Chip® at Florida Simulation Summit 2020
                                Hesperos Chief Scientist, Dr. James Hickman discusses how a Human-on-a-Chip works at the Florida Simulation Summit 2020
                                The post Dr. Hickman Presents Human-on-a-Chip® at Florida Simulation Summit 2020 appeared first on Hesperos Inc..
                                
                                  Improved Nature - Nature’s PRIME Mini Pieces™ Feta and Spinach Phyllo Tartletts
                                  The post Nature’s PRIME Mini Pieces™ Feta and Spinach Phyllo Tartletts appeared first on Improved Nature.
                                  
                                    Irras - Neurocritical Education Specialist
                                    SUMMARY: The Neurocritical Education Specialist will function within the commercial division of the IRRAS organization to support the product launch and training for the IRRAflow and Hummingbird ICP product families.  This role’s primary responsibility will be to support the achievement of the company’s defined sales revenue targets by providing world class education, training, and product […]
                                    The post Neurocritical Education Specialist appeared first on IRRAS.
                                    
                                      Kenzen - EWTS 2020: Preventing Heat Injuries in Japan
                                      EWTS 2020 presentation with Kenzen CCO Heidi Lehmann and Yuji Doi, Technology Development Manager at Kajima International
                                        Kindred Biosciences - Event: Kindred Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
                                        Tuesday, November 17 Presentation time: 2:40 – 3:10p.m. ET Company Attendee: CEO Richard Chin Webcast URL: Click here For more information about this event, please see the press release.
                                        The post Event: Kindred Biosciences to Present at Stifel 2020 Virtual Healthcare Conference appeared first on KindredBio.
                                        
                                          Kura Oncology - The University of Texas MD Anderson Cancer Center
                                          Houston, Texas, United States, 77030
                                          The post The University of Texas MD Anderson Cancer Center first appeared on Kura Oncology.
                                            Locus Biosciences - Locus Biosciences signs contract with CARB-X to advance $14 million precision medicine program to develop crPhage™ product targeting Klebsiella pneumoniae infections
                                            Morrisville, NC – November 10, 2020  – Locus Biosciences, a clinical-stage biopharmaceutical company, announced today that it has signed a contract with the global non-profit, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to fund up to $12.5 million of a $14.8 million program for development of LBP-KP01, a CRISPR Cas3-enhanced bacteriophage (crPhage™) product targeting the bacterial […]
                                              Nicoya Lifesciences - OpenSPR Binding Data Reveals a Potential Mechanism for the Treatment of Depression
                                              Introduction Depression is becoming more and more common worldwide, with approximately 1 in 30 people being affected by the illness[1]. Resulting from a combination of genetic, social and psychological factors, depression impacts one’s quality of living and can range in severity, from affecting their motivation for daily tasks to being completely debilitating. Modern medicine’s impact […]
                                              The post OpenSPR Binding Data Reveals a Potential Mechanism for the Treatment of Depression appeared first on Nicoya - Improving Human Life by Helping Scientists Succeed.
                                              
                                                OncoMyx Therapeutics - FierceBiotech: Arming the rabbit pox virus to fight cancer
                                                Oncolytic viruses hold promise as cancer treatments due to their cancer-killing prowess and ability to be combined with other therapies. But few drugs derived from oncolytic viruses have made it to the market. Arizona State University spinout OncoMyx Therapeutics is designing anti-cancer therapies from a type of rabbit pox virus called myxoma. The company has early data […]
                                                The post FierceBiotech: Arming the rabbit pox virus to fight cancer appeared first on OncoMyx Therapeutics.
                                                
                                                  Rallybio - Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
                                                  RLYB211 is in Clinical Development for the Prevention of FNAIT, a Potentially Life-Threatening Rare Disorder that Impacts Fetuses and Newborns NEW HAVEN, Conn., November 10, 2020 – Rallybio, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, today announced that dosing has commenced in […]
                                                    Shattuck Labs - Senior Director of Cell Line Development
                                                    Durham, NC
                                                    The post Senior Director of Cell Line Development appeared first on Shattuck Labs.
                                                    
                                                      TScan Therapeutics - TScan Therapeutics Announces Partnership with QIAGEN to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response
                                                      QIAGEN Secures Option to License Discoveries from TScan’s TCR/Target ID Platform for Use in Potential Diagnostics for COVID-19 WALTHAM, Mass.–(BUSINESS WIRE)– TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology, today announced the signing of a research license and option agreement with QIAGEN to develop T … Continued
                                                      The post TScan Therapeutics Announces Partnership with QIAGEN to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response appeared first on TScan Therapeutics.
                                                      
                                                        TScan Therapeutics - TScan Therapeutics Announces Presentations at Upcoming Conferences
                                                        WALTHAM, Mass.–(BUSINESS WIRE)–TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology, today announced that management will present virtually at the following upcoming medical meeting and healthcare conferences: The Society for Immunotherapy of Cancer Annual Meeting (SITC) Gavin MacBeath, Ph.D., Chief Scientific Officer, will present an e- … Continued
                                                        The post TScan Therapeutics Announces Presentations at Upcoming Conferences appeared first on TScan Therapeutics.